Makary's exit creates new uncertainty at FDA His departure won't solve the organizational upheaval and political jockeying that marked much of his tenure. Axios · May 13
Trump warns thousands of pharma companies over "deceptive ads" The FDA said it's sending out 100 cease-and-desist letters and warning thousands of others over ads it says are "misleading." Axios · Sep 10, 2025
Cassidy says canceled vaccine research needed to fight pandemics - Roll Call The chairman of the Senate Health, Education, Labor and Pensions Committee denounced a decision by the federal government to phase out mRNA vaccine development, warning that could hurt pandemic preparedness. Roll Call · Aug 7, 2025
Medicare Advantage Customers Face Shrinking Pool of Insurers Medicare Advantage plan insurers are reducing their enrollments as profit margins shrink. Kiplinger · Sep 12, 2024
Hospital and insurer battles over Medicare Advantage set to grow Some providers have already taken the extraordinary step of terminating contracts with Medicare plans. Axios · Apr 4, 2024
New COVID lab leak assessment reignites furor over pandemic origins A new U.S. government assessment that COVID-19 likely originated from a lab leak in China is sure to add fuel to House oversight hearings into the pandemic's origins and have a bearing on future funding for the National Institutes of Health. Axios · Feb 27, 2023
What to know about new COVID boosters Experts answer some top questions about Omicron-specific COVID boosters. Axios · Sep 1, 2022